Co-Authors
This is a "connection" page, showing publications co-authored by Arnon Afek and Gili Regev-Yochay.
Connection Strength
0.531
-
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug; 7:100150.
Score: 0.239
-
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open. 2021 08 02; 4(8):e2122255.
Score: 0.060
-
COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply. Lancet. 2021 06 12; 397(10291):2249-2250.
Score: 0.059
-
Establishing a COVID-19 treatment centre in Israel at the initial stage of the outbreak: challenges, responses and lessons learned. Emerg Med J. 2021 May; 38(5):373-378.
Score: 0.059
-
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021 03 06; 397(10277):875-877.
Score: 0.058
-
Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience. Isr Med Assoc J. 2020 Aug; 22(8):470-475.
Score: 0.056